Market Context
The broad-market trend is constructive, while the current market pulse is adverse and the market-risk posture is defensive. The current Healthcare sector pulse is mixed, while its short-term outlook is mixed, with no clear directional read. That current reading differs from the forward sector outlook. Broad-market measures include breadth of 35.40%, capitalization-weighted return of -0.21%, and equal-weight return of -0.94%. Healthcare measures include breadth of 22.44%, capitalization-weighted return of -1.01%, and equal-weight return of -1.87%.
STAA — STAAR Surgical Company
WATCH LONG | October 13, 2026
Setup
STAA remains a WATCH long setup, with the preferred entry zone anchored to established support.
Key Levels
- Reference Price (as of October 13, 2026): $21.52
- Analyst Consensus Target: $28.00
- Reference upside: 30.11%
- Reference reward/risk: 5.79
- Preferred Entry Zone: $20.85–$23.09
- Entry Risk: 5.20% from entry
Why It Stands Out
Additional support comes from the fundamental profile and a defined reward/risk profile.
Risk & Timing
Forward sector conditions remain a headwind: the near-term outlook is adverse. Stock-level model direction is downward over the immediate. Participation remains light.
Bottom Line
STAA remains a WATCH long setup. Entry timing triggered the WATCH classification, while adverse forward Healthcare conditions remain an additional constraint.
Research Snapshot
Valuation & Fundamentals
Valuation measures include trailing P/E of 270.88x and forward P/E of 62.50x. Profitability measures include ROA of 5.65%, ROE of 1.09%, operating margin of 10.90% and net margin of 1.13%. Balance-sheet and volatility context includes total liabilities to equity of 0.34 and beta of 1.18. The Fundamental Sentiment Score is 0.37.
Technical Context
Historical ranges include 21-day range of $19.05–$22.97, 40-day range of $19.05–$24.37 and 52-week range of $15.59–$35.87.
Risks & Catalysts
Earnings are estimated for November 4, 2026 and remain an event risk.
